Biomarker Seeks Future Test Candidates

Biomarker Technologies, the worldwide technology provider of the BT Test, is beginning a nationwide mobilization of women and physicians who want to become involved in upcoming clinical studies for this first-of-its-kind diagnostic blood test for breast cancer. The company is seeking both healthy women and those with recently diagnosed breast cancer, as well as physicians who are interested in being contacted for more information. When new studies are launched, those who sign up will be contacted first with complete study details and requirements. The studies are part of the FDA premarket approval process for the BT Test.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=516544XSL_NEWSML_TO_NEWSML_WEB.xml)